“Glenmark Pharma Share Price Today”
₹2,181.55 (14.51%)
Glenmark Pharmaceuticals Stock Surges Over 14% – What’s Happening?
July 11, 2025, 15:59:57 PM IST
Glenmark Pharmaceuticals is currently trading 14.51% higher at ₹2,181.55, showing a strong upward movement compared to its last closing price. In recent trading sessions, the stock has moved between ₹2,095.65 and ₹2,286.15, indicating good volatility.
So far in 2025, Glenmark has delivered a return of 18.33%, and in just the last five days, it has increased by 6.76%—a strong short-term performance.
Glenmark Pharmaceuticals is currently trading 14.51% higher at ₹2,181.55, showing a strong upward movement compared to its last closing price. In recent trading sessions, the stock has moved between ₹2,095.65 and ₹2,286.15, indicating good volatility. So far in 2025, Glenmark has given a return of 18.33%, and in just the last 5 days, it has gone up by 6.76% – a strong short-term performance.Financial Performance
Glenmark reported a net profit of ₹4.65 crores in its most recent quarter. Although this number is on the lower side, investor interest in the stock has still increased.
Mutual Fund and FII Holdings
Mutual fund holdings in Glenmark stood at 12.86% as of March 31, 2025, and this has increased from the previous quarter, a positive sign.
Foreign Institutional Investors (FIIs) held 23.15% of the stock, but this has decreased, showing a slight decline in interest from international investors.
Peer Comparison
Glenmark is outperforming some of its listed peers:
- Alkem Laboratories is up 1.42%
- GlaxoSmithKline Pharmaceuticals is down 0.33%
- Glenmark Pharmaceuticals is up a strong 14.51%
Glenmark Pharma is showing strong momentum in 2025, gaining investor attention with a 14% rise in one day. With mutual fund interest rising and the stock outperforming its sector peers, it’s one to watch. However, a high P/E ratio and low recent profit may also suggest caution for new investors.
